ST Elevation Myocardial Infarction Clinical Trial
Official title:
In-Hospital Outcome of Primary Percutaneous Coronary Intervention in Addict ST Elevation Myocardial Infarction Patients in Assuit University Hospital.
• The goal of this study is to Identify the in-hospital outcome of primary PCI in treatment of STEMI in addict patients in comparison to non-addict patients.
Myocardial infarction (MI), is a type of acute coronary syndrome, in which there is damage to
the cardiac muscle as demonstrated by increased cardiac Troponin levels in the setting of
acute ischemia (1). Myocardial infarction (MI) is a fatal disease that is caused by block in
the oxygen supply of blood vessels of the heart muscle, leading to permanent heart muscle
damage and death of its cells. According to world health organization (WHO) report published
in 2014, 68% of global deaths annually related to non communicable diseases, Cardiovascular
diseases constitute 31% of these deaths denoting that they are the leading cause of death
(2). Risk factors of cardiovascular diseases include behavioral factors as eating un healthy
food, smoking, alcohol intake, and other substance abuse.
Regarding management of MI, There have been several studies that have shown the superiority
of percutaneous coronary intervention (PCI) as a treatment for ST-elevation myocardial
infarction (STEMI) when compared with thrombolytic therapy in terms of reducing mortality
rate and recurrence of myocardial infarction (MI) [3-5].
Regarding Drug abuse cardiovascular effects. It depends on the drug, dose, and route of
administration, cardiovascular consequences can range from innocuous side effects, to life
threatening ventricular arrhythmias and myocardial infarction.
Sympathomimetic drugs like amphetamines cause an increase in release of peripheral
catecholamines stimulating increases in heart rate, systemic vascular resistance, and cardiac
contractility, thus resulting in augmentation of cardiac output and blood pressure. In
contrast, several drugs are directly cardiodepressant in the acute setting, and many drugs of
both types are cardiotoxic causing cardiomyopathy and congestive heart failure with long-term
use.
Changes in the balance of myocardial oxygen supply and demand with drug use can lead to
myocardial ischemia. For example, cocaine increases oxygen demand in the myocardium while
simultaneously decreasing supply by inducing epicardial coronary vasoconstriction. Modulation
of lipid profiles, coagulation factors, platelet function, and inflammation further heighten
the risk of cardiac ischemic events in patients using these drugs.
Many recreational drugs are arrhythmogenic in the acute setting or during
abstinence/withdrawal. Mechanisms of arrhythmias are complex and likely result from interplay
between the direct effects of drugs, electrolyte derangements, sympathetic nervous
alterations, and cardiac ischemia.(6)
Substance Use Disorders (SUD) are considered to be prevalent In Middle Eastern Arab
countries, particularly Egypt, but there is scarce information on the problem of patients
with substance abuse or dependence attending emergency rooms in general hospitals.
In across sectional study done in EL Mansoura University in 2012, Among patients with
substance abuse, cannabis ranked first (3.6%) then tramadol 1.8%, polysubstance1.7%, followed
by stimulants group (1.3%), alcohol (1.1%), and finally anticholinergics (0.5%) and volatile
substances (0.3%). Urine toxicology shows that 30% used at least one of these illicit drugs:
(20%) tested positive for cannabis, (6%) had a positive urine screen for amphetamine, and
(10%) tested positive for opiates.(7)
Prior studies have reported discrepant results on the association between substance use
disorders and access to Primary PCI after acute myocardial infarct (AMI) [8]. Druss and
colleagues showed that patients with SUDs aged 65 and older in acute care non-governmental
hospitals in the United States were less likely than those with neither mental nor substance
use disorder to receive cardiac catheterization after acute MI [9]. Young reported data
stratified by age, indicating that patients with SUDs both younger and older than 65 years
have lower rates of cardiac procedures and higher rates of in-hospital mortality compared
with those with neither mental nor substance use disorders [10]. Most recently, Jones and
colleagues published results from an analysis of administrative data from a large
commercially insured sample of all ages, adjusting for comorbidities.(11) They obtained an
unexpected result: those with SUDs were more likely to receive percutaneous coronary
intervention (PCI) in comparison to those with neither mental nor substance use disorders.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05601999 -
Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial Infarction
|
Phase 3 | |
Recruiting |
NCT06147986 -
Evaluate the Efficacy and Safety of Allogeneic Umbilical Cord Mesenchymal Stem Cells as an Add-On Treatment for Acute ST-elevation Myocardial Infarction (STEMI) Patients
|
Phase 2 | |
Not yet recruiting |
NCT05881382 -
Dutogliptin in Co-administration With Filgrastim in Early Recovery Post-myocardial Infarction
|
Phase 3 | |
Enrolling by invitation |
NCT02615015 -
SNPs in the DNase 1 Gene Impair Its Activity and Are Increased in a STE-ACS Patient Cohort Compared to Healthy Controls
|
N/A | |
Recruiting |
NCT05812963 -
IVUS Versus FFR for Non-infarct Related Artery Lesions in Patients With Multivessel Disease and Acute STEMI
|
N/A | |
Recruiting |
NCT05554588 -
Intrathrombus Thrombolysis Versus Aspiration Thrombectomy During Primary PCI
|
N/A | |
Recruiting |
NCT05450757 -
Shanghai ST-segment Elevation Myocardial Infarction Cohort
|
||
Active, not recruiting |
NCT03278509 -
Evaluation of Decreased Usage of Betablockers After Myocardial Infarction in the SWEDEHEART Registry (REDUCE-SWEDEHEART)
|
Phase 4 | |
Not yet recruiting |
NCT03266328 -
Procedure and In-hospital Outcome of Patients Under 40 Years Old Undergoing Primary Percutaneous Coronary Intervention for Acute ST Elevated Myocardial Infarction in Assiut University
|
N/A | |
Completed |
NCT03156699 -
The Incidence, Effect and Persistence of Fragmented-QRS, in Patients Presenting With ST-Elevation Myocardial Infarction
|
||
Not yet recruiting |
NCT03263468 -
Revascularization StrategIes for ST Elevation Myocardial Infarction Trial
|
N/A | |
Enrolling by invitation |
NCT04970238 -
Effect of Levosimendan on Left Ventricular Systolic Function and Heart Failure After PCI in Patients With Acute Anterior Myocardial Infarction
|
Phase 4 | |
Recruiting |
NCT02557217 -
NP202 for Treatment of Post -STEMI Left Ventricular Systolic Dysfunction
|
Phase 2 | |
Recruiting |
NCT02224534 -
Ticagrelor Versus Clopidogrel in Left Ventricular Remodeling After ST-segment Elevation Myocardial Infarction
|
Phase 4 | |
Completed |
NCT01136187 -
Trial Comparing Radial and Femoral Approach in Primary Percutaneous Coronary Intervention (PCI)
|
N/A | |
Not yet recruiting |
NCT04068116 -
Impact of Ischemic Post-conditioning
|
N/A | |
Not yet recruiting |
NCT04063345 -
Long-term Clinical Outcomes of intraVascular Ultrasound-guided vs Angiography-guided Primary pErcutaneous Intervention in Patients With Acute ST Segment Elevated Myocardial Infarction
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT03646357 -
BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function
|
Phase 4 | |
Completed |
NCT03740776 -
The Eosinophils Percentage Predicts In-hospital Major Adverse Cardiac Events in STEMI Patients After PCI
|
||
Completed |
NCT03984071 -
The Predictive Value of eGFR for Adverse Cardiovascular Events in Patients With STEMI
|